Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Safety and Effectiveness of Apixaban, LMWH, and Warfarin Among Venous Thromboembolism Patients with Active Cancer: A Retrospective Analysis Using Four US Claims Databases

Alexander T Cohen, MBBS, MSc, MD, Allison Keshishian, Theodore Lee, MD, Gail Wygant, RN, MS, Lisa Rosenblatt, MD MPH, Patrick Hlavacek, MPH, Jack Mardekian, PhD, Daniel Wiederkehr, MPH, Janvi Sah, MS, Xuemei Luo, PhD

Blood (2019) 134 (Supplement_1): 326.

https://doi.org/10.1182/blood-2019-121769

Published: 2019

Journal Articles

Safety and Effectiveness of Apixaban, LMWH and Warfarin Among Venous Thromboembolism (VTE) Patients with Active Cancer: A Subgroup Analysis of VTE Risk Scale

Blood (2019) 134 (Supplement_1): 327.

https://doi.org/10.1182/blood-2019-126931

Published: 2019

Journal Articles

Factor VIII Levels in Blood Group O and Non-O in Patients with Non-Severe Haemophilia a

Judit Rejtoe, MD, Oliver Königsbrügge, MD, Ella Grilz, MD, Stefanie Hofer, Johanna Gebhart, MD, Gerhard Schuster, MD, Clemens Feistritzer, MD, Peter Quehenberger, MD, Cihan Ay, MD, Ingrid Pabinger, MD

Blood (2019) 134 (Supplement_1): 1135.

https://doi.org/10.1182/blood-2019-123187

Published: 2019

Journal Articles

Incidence, Clinical Profile and Outcome of Patients with Deep Vein Thrombosis and Pulmonary Embolism at a Community Hospital

Pragathi Balakrishna, MD, Mehdi M. Moezi, MD, Furquan Pathan, MD

Blood (2017) 130 (Supplement 1): 5585.

https://doi.org/10.1182/blood.V130.Suppl_1.5585.5585

Published: 2017

Journal Articles

Location Matters in Nodal Diffuse Large B-Cell Lymphoma

Konstantinos Lontos, MD, Anastasia Tsagianni, MD, Swathi Namburi, Arpita Gandhi, MD BA, Jian-Min Yuan, MD PhD, Daniel Normolle, PhD, Michael Boyiadzis, MD, Steven H. Swerdlow, MD, Kathleen A. Dorritie, MD

Blood (2017) 130 (Supplement 1): 2854.

https://doi.org/10.1182/blood.V130.Suppl_1.2854.2854

Published: 2017

Journal Articles

A Risk Prediction Model for Severe Chemotherapy-Induced Anemia in Breast Cancer Patients

Chun Chao, PhD, Lanfang Xu, MSc, Leila Family, PhD MPH, Hairong Xu, MD PhD

Blood (2016) 128 (22): 2399.

https://doi.org/10.1182/blood.V128.22.2399.2399

Published: 2016

Journal Articles

Direct Oral Anticoagulants in Patients with Cancer

Surbhi Shah, MBBS, Yvonne H Datta, MD, Faye Norby, MS, MPH, Alvaro Alonso, MD PhD MPH, FAHA

Blood (2016) 128 (22): 877.

https://doi.org/10.1182/blood.V128.22.877.877

Published: 2016

Journal Articles

Quality of Life in Cancer Patients Undergoing Anticoagulant Treatment for Venous Thromboembolism: The Quavitec Study

Dominique Farge, MD PhD, Nicolas Falvo, MD, Matthieu Resche-Rigon, MD PhD, Toufek Berremili, MD, Francis Couturaud, MD PhD, Okba Bensaoula, MD, Lionel Védrine, MD, Isabelle Bonnet, MD, Denis Péré-Vergé, MD, Marie Coudurier, MD, Veronique Li, MD, Francis Cajfinger, MD

Blood (2016) 128 (22): 880.

https://doi.org/10.1182/blood.V128.22.880.880

Published: 2016

Journal Articles

Major Bleeding Events Among Cancer and Non-Cancer Patients Taking Rivaroxaban for Venous Thromboembolism Treatment in a Department of Defense Health System Cohort

Alok A. Khorana, MD, Frank Peacock, MD, Sally G Tamayo, MD, Zhong Yuan, MD, Nicholas Sicignano, MPH, Kathleen Hopf, MPH, Manesh Patel, MD

Blood (2016) 128 (22): 1447.

https://doi.org/10.1182/blood.V128.22.1447.1447

Published: 2016

Journal Articles

Efficacy and Safety of Four Factor Prothrombin Complex Concentrates As a Reversal Agent for Oral Xa Inhibitors

Krishna Gundabolu, MD, Brian Trevarrow, BA, Pharm.D., BCPS, Scott A Koepsell, MD, PhD, FCAP

Blood (2015) 126 (23): 4668.

https://doi.org/10.1182/blood.V126.23.4668.4668

Published: 2015

Journal Articles

Unique Versus Common: Disease-Biased Immunoglobulin Gene Repertoires Along with Public Antigen Receptor Stereotypes in Marginal Zone B-Cell Lymphoproliferations

Blood (2015) 126 (23): 1479.

https://doi.org/10.1182/blood.V126.23.1479.1479

Published: 2015

Journal Articles

Role of Extended Thromboprophylaxis after Abdominal and Pelvic Surgery in Cancer Patients: A Systematic Review and Meta-Analysis

Andrei Fagarasanu, MD PhD, Ghazi S Alotaibi, MD, Ramona Hrimiuc, MD, Agnes Y. Y. Lee, MDMSc, Cynthia Wu, MD

Blood (2015) 126 (23): 2324.

https://doi.org/10.1182/blood.V126.23.2324.2324

Published: 2015

Journal Articles

Variable Support Towards ASCO Recommendations for Venous Thromboembolism (VTE) Prophylaxis and Treatment in Patients with Cancer

Axel Matzdorff, MD PhD, Uwe Schwindel, MD, Michael Mueller, Hans Joachim Hutt, MD

Blood (2015) 126 (23): 5564.

https://doi.org/10.1182/blood.V126.23.5564.5564

Published: 2015

Journal Articles

An Open-Label, Phase 2, Multicenter Study Of The Safety Of Long-Term Treatment With Siltuximab (an Anti-Interleukin-6 Monoclonal Antibody) In Patients With Multicentric Castleman’s Disease

Frits Van Rhee, Corey Casper, Peter M Voorhees, Luis E Fayad, Helgi van de Velde, Jessica Vermeulen, Xiang Qin, Ming Qi, Brenda Tromp, Razelle Kurzrock

Blood (2013) 122 (21): 1806.

https://doi.org/10.1182/blood.V122.21.1806.1806

Published: 2013

Journal Articles

The Influence of the Duration of Storage of Red Blood Cells On Cancer Survival

Natasha Kekre, MD, FRCPC, Ranjeeta Mallick, David S. Allan, MD, MSc, Alan Tinmouth, MD, FRCPC, Jason Tay, MD, MSc, FRCPC

Blood (2012) 120 (21): 1184.

https://doi.org/10.1182/blood.V120.21.1184.1184

Published: 2012

Journal Articles

Association Study of Microrna and Microrna-Biogenesis Gene Polymorphisms with Venous Thromboembolism (VTE) in Korean Population

Nam Keun Kim, Young Joo Jeon, Moon Ju Jang, Doyeun Oh

Blood (2012) 120 (21): 3395.

https://doi.org/10.1182/blood.V120.21.3395.3395

Published: 2012

Journal Articles

Incidental Pulmonary Embolism in Cancer Patients: Clinical Features and Outcome.

Giulia Piacentini, Vittorio Fregoni, MD, Gianpiero Rizzo, MD, Gian Antonio Da Prada, MD, Isabella Thea Lorenzetti, MD, Giulia Gallizzi, MD, Lorenzo Pavesi, MD, Alberto Riccardi, Prof, MD

Blood (2012) 120 (21): 2243.

https://doi.org/10.1182/blood.V120.21.2243.2243

Published: 2012

Journal Articles

Risk of Recurrence of Venous Thromboembolism After Major Surgery for Cancer,

Aurelien Delluc, Patrice Crenn, Emmanuelle Le Moigne, Francis Couturaud, MD, PhD, Gregoire Le Gal, MD, PhD, Dominique Mottier, Karine Lacut

Blood (2011) 118 (21): 3342.

https://doi.org/10.1182/blood.V118.21.3342.3342

Published: 2011

Journal Articles

Rate and Time Course of Thromboembolism Events in Cancer Patients

Russell D Hull, Tazmin Merali, BPharm, MBA, Allan Mills, PharmD, Jane Liang, Nelly Komari, BPharm, MSc

Blood (2011) 118 (21): 4773.

https://doi.org/10.1182/blood.V118.21.4773.4773

Published: 2011

Journal Articles

Outcomes of Pulmonary Embolism In Surgical Patients: A Retrospective Cohort Study

Gauruv Bose, Esteban Gandara, Marc Carrier, MD, MSc, Petra Erkens, MG, Marc Rodger, Philip Wells, MD, FRCPC, MSc

Blood (2010) 116 (21): 3180.

https://doi.org/10.1182/blood.V116.21.3180.3180

Published: 2010

NARROW

Safety and Effectiveness of Apixaban, LMWH, and Warfarin Among Venous Thromboembolism Patients with Active Cancer: A Retrospective Analysis Using Four US Claims Databases

Safety and Effectiveness of Apixaban, LMWH and Warfarin Among Venous Thromboembolism (VTE) Patients with Active Cancer: A Subgroup Analysis of VTE Risk Scale

Factor VIII Levels in Blood Group O and Non-O in Patients with Non-Severe Haemophilia a

Incidence, Clinical Profile and Outcome of Patients with Deep Vein Thrombosis and Pulmonary Embolism at a Community Hospital

Location Matters in Nodal Diffuse Large B-Cell Lymphoma

A Risk Prediction Model for Severe Chemotherapy-Induced Anemia in Breast Cancer Patients

Direct Oral Anticoagulants in Patients with Cancer

Quality of Life in Cancer Patients Undergoing Anticoagulant Treatment for Venous Thromboembolism: The Quavitec Study

Major Bleeding Events Among Cancer and Non-Cancer Patients Taking Rivaroxaban for Venous Thromboembolism Treatment in a Department of Defense Health System Cohort

Efficacy and Safety of Four Factor Prothrombin Complex Concentrates As a Reversal Agent for Oral Xa Inhibitors

Unique Versus Common: Disease-Biased Immunoglobulin Gene Repertoires Along with Public Antigen Receptor Stereotypes in Marginal Zone B-Cell Lymphoproliferations

Role of Extended Thromboprophylaxis after Abdominal and Pelvic Surgery in Cancer Patients: A Systematic Review and Meta-Analysis

Variable Support Towards ASCO Recommendations for Venous Thromboembolism (VTE) Prophylaxis and Treatment in Patients with Cancer

An Open-Label, Phase 2, Multicenter Study Of The Safety Of Long-Term Treatment With Siltuximab (an Anti-Interleukin-6 Monoclonal Antibody) In Patients With Multicentric Castleman’s Disease

The Influence of the Duration of Storage of Red Blood Cells On Cancer Survival

Association Study of Microrna and Microrna-Biogenesis Gene Polymorphisms with Venous Thromboembolism (VTE) in Korean Population

Incidental Pulmonary Embolism in Cancer Patients: Clinical Features and Outcome.

Risk of Recurrence of Venous Thromboembolism After Major Surgery for Cancer,

Rate and Time Course of Thromboembolism Events in Cancer Patients

Outcomes of Pulmonary Embolism In Surgical Patients: A Retrospective Cohort Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only